Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://kianaeirg334378.blogoscience.com/45577088/retaglutide-a-promising-glp-1-receptor-agonist